Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated with Neoadjuvant Therapy in the GeparQuinto Trial

<i>Background</i>: Remodeling of extracellular matrix through collagen degradation is a crucial step in the metastatic cascade. The aim of this study was to evaluate the potential clinical relevance of the serum collagen degradation markers (CDM) C3M and C4M during neoadjuvant chemothera...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Malgorzata Banys-Paluchowski, Sibylle Loibl, Isabell Witzel, Christoph Mundhenke, Bianca Lederer, Christine Solbach, Thomas Karn, Frederik Marmé, Valentina Nekljudova, Christian Schem, Elmar Stickeler, Nicholas Willumsen, Morten A. Karsdal, Michael Untch, Volkmar Müller
Format: Artigo
Jezik:Inglês
Izdano: MDPI AG 2019-08-01
Serija:Cancers
Teme:
breast cancer
C3M
C4M
collagen degradation marker
neoadjuvant therapy
trastuzumab
lapatinib
Online pristup:https://www.mdpi.com/2072-6694/11/8/1186
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items